{"filing":{"accession_number":"0001493152-26-041616","cik":"0001716166","ticker":"VVOS","company_name":"Vivos Therapeutics, Inc.","form":"8-K","filing_date":"2026-09-04","report_date":"2026-08-31","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226041616/form8-k.htm"},"events":[{"id":31688,"run_id":29087,"accession_number":"0001493152-26-041616","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses unregistered sales of equity securities under Item 3.02, specifically the issuance of up to 11,445,080 shares of Common Stock (approximately 52% of pre-exchange outstanding shares) to Streeterville Capital in exchange for cancellation of $2.86 million in debt principal. The shares are issued in reliance on Section 3(a)(9) of the Securities Act without registration, representing a highly dilutive transaction that materially increases share count from 22.2 million to 33.6 million shares outstanding.","company_name":"Vivos Therapeutics, Inc.","ticker":"VVOS","filing_date":"2026-09-04","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":34635,"accession_number":"0001493152-26-041616","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses unregistered sales of equity securities under Item 3.02, specifically the issuance of up to 11,445,080 shares of Common Stock (approximately 52% of pre-exchange outstanding shares) to Streeterville Capital in exchange for cancellation of $2.86 million in debt principal. The shares are issued in reliance on Section 3(a)(9) of the Securities Act without registration, representing a highly dilutive transaction that materially increases share count from 22.2 million to 33.6 million shares outstanding.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T10:02:10.700241+00:00","company_name":"Vivos Therapeutics, Inc.","ticker":"VVOS","filing_date":"2026-09-04"}]}